Neuphoria Therapeutics (NEUP) Institutional Ownership $7.13 +0.11 (+1.57%) As of 07/3/2025 01:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsOwnershipSEC FilingsTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Neuphoria Therapeutics (NASDAQ:NEUP)CurrentInstitutional OwnershipPercentage15.90%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$57.60KNumber ofInstitutional Sellers(last 12 months)0 Get NEUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Neuphoria Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Neuphoria Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/17/2025Cyndeo Wealth Partners LLC10,000$58K0.0%N/A0.569% 2/14/2025Jane Street Group LLC13,311$46K0.0%N/A0.817% 2/14/2025Lynx1 Capital Management LP45,806$157K0.1%N/A2.810% (Data available from 1/1/2016 forward) NEUP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NEUP shares? During the previous two years, the following institutional investors and hedge funds held shares of Neuphoria Therapeutics shares: Lynx1 Capital Management LP ($157K), and Cyndeo Wealth Partners LLC ($58K), Jane Street Group LLC ($46K).Learn more on Neuphoria Therapeutics' institutional investors. What percentage of Neuphoria Therapeutics' stock is owned by institutional investors? 15.90% of Neuphoria Therapeutics' stock is owned by institutional investors. Learn more on NEUP's institutional investor holdings. Which institutional investors have been buying Neuphoria Therapeutics' stock? The following institutional investors have purchased Neuphoria Therapeutics' stock in the last 24 months: Lynx1 Capital Management LP ($45.81K), Jane Street Group LLC ($13.31K), and Cyndeo Wealth Partners LLC ($10K). How much institutional buying is happening at Neuphoria Therapeutics? Institutional investors have bought a total of 69,117 shares in the last 24 months. This purchase volume represents approximately $57.60K in transactions. Related Companies IPA Institutional Ownership TELO Institutional Ownership VTVT Institutional Ownership RNXT Institutional Ownership IPSC Institutional Ownership BLUE Institutional Ownership PRLD Institutional Ownership STTK Institutional Ownership AADI Institutional Ownership ATRA Institutional Ownership This page (NASDAQ:NEUP) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuphoria Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuphoria Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
